Exchange: NASDAQ·Updated 04:39 PM EDT
News
all
press releases
Lisata Therapeutics Seeks $2 Mln Termination Fee Over Merger Dispute With Kuva, Cuts 72% Workforce
(RTTNews) - Tuesday, Lisata Therapeutics, Inc. (LSTA) announced it has filed a lawsuit against Kuva Labs Inc. and its subsidiary, Kuva Acquisition Corp., in the Delaware Court of Chancery over breach of the merger agreement...
Nasdaq News: Markets
More News
Lisata Therapeutics Stock Falls After Hours: Here's Why
Lisata Therapeutics stock fell after hours after updating investors on its pending acquisition and tender offer.read more...
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics (NASDAQ:LSTA)read more...
Benzinga
Are LSTA, MCHX, CZR Obtaining Fair Deals for their Shareholders?
Are LSTA, MCHX, CZR Obtaining Fair Deals for their Shareholders? Are LSTA, MCHX, CZR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 16, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
Are SILA, KALV, THR, LSTA Obtaining Fair Deals for their Shareholders?
Are SILA, KALV, THR, LSTA Obtaining Fair Deals for their Shareholders? Are SILA, KALV, THR, LSTA Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 14, 2026 Insiders may stand to...
PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders Shareholder Alert: The Ademi Firm investigates whether Lisata...
PR Newswire
Why Lisata Therapeutics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken private by Kuva Labs for $5.00 per share + $1.00 CVR.read more...
Benzinga
Lisata Therapeutics Agrees To Be Taken Private By Kuva Labs
(RTTNews) - Lisata Therapeutics Inc. (LSTA) announced that it has entered into a definitive agreement to be acquired by Kuva Labs Inc., a privately held company. Under the terms of the merger...
Nasdaq News: Markets
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders? Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Feb. 11, 2026 Insiders may stand to...
PR Newswire
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their...
PR Newswire

Advertisement|Remove ads.